The Stryker Co. (SYK) to Issue Quarterly Dividend of $0.43 on April 28th – Petro Global News 24

Stryker Co. (NYSE:SYK) declared a quarterly dividend on Wednesday, February 8th. Stockholders of record on Friday, March 31st will be given a dividend of 0.425 per share by the medical technology company on Friday, April 28th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date of this dividend is Wednesday, March 29th.

Stryker (NYSE:SYK) opened at 132.49 on Tuesday. The stock has a 50 day moving average price of $128.69 and a 200-day moving average price of $119.60. Stryker has a 1-year low of $104.61 and a 1-year high of $133.59. The stock has a market capitalization of $49.40 billion, a P/E ratio of 30.46 and a beta of 0.80.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, January 24th. The medical technology company reported $1.78 EPS for the quarter, topping analysts consensus estimates of $1.76 by $0.02. The company earned $3.20 billion during the quarter, compared to the consensus estimate of $3.15 billion. Stryker had a net margin of 14.54% and a return on equity of 23.86%. Strykers revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.56 earnings per share. Equities research analysts expect that Stryker will post $6.41 EPS for the current year.

SYK has been the subject of a number of recent research reports. Needham & Company LLC reissued a sell rating on shares of Stryker in a research note on Wednesday, January 25th. Wells Fargo & Co reissued an outperform rating and issued a $134.50 price objective on shares of Stryker in a research note on Saturday, January 28th. Jefferies Group LLC boosted their price objective on shares of Stryker from $120.00 to $132.00 and gave the stock a hold rating in a research note on Wednesday, January 25th. Edward Jones downgraded shares of Stryker from a buy rating to a hold rating in a research note on Thursday, January 5th. Finally, Zacks Investment Research raised shares of Stryker from a hold rating to a buy rating and set a $125.00 price objective for the company in a research note on Monday, December 5th. Two analysts have rated the stock with a sell rating, seven have given a hold rating and thirteen have issued a buy rating to the companys stock. Stryker has a consensus rating of Buy and an average target price of $127.74.

In related news, VP Yin C. Becker sold 4,398 shares of the companys stock in a transaction dated Wednesday, February 15th. The shares were sold at an average price of $125.27, for a total transaction of $550,937.46. Following the completion of the transaction, the vice president now owns 12,541 shares in the company, valued at approximately $1,571,011.07. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Louise Francesconi sold 3,716 shares of the companys stock in a transaction dated Monday, January 30th. The stock was sold at an average price of $122.34, for a total transaction of $454,615.44. Following the transaction, the director now owns 20,242 shares of the companys stock, valued at approximately $2,476,406.28. The disclosure for this sale can be found here. Over the last three months, insiders have sold 24,968 shares of company stock worth $3,033,715. Corporate insiders own 7.80% of the companys stock.

About Stryker

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Companys segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Go here to read the rest:

The Stryker Co. (SYK) to Issue Quarterly Dividend of $0.43 on April 28th - Petro Global News 24